Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:MITO 25 August 2025

FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

The FDA approved Ionis’ Dawnzera as the first RNA-targeted preventive treatment for hereditary angioedema, after trials showed an 81% drop in attack rates. Regulators rejected PTC Therapeutics’ vatiquinone for Friedreich’s ataxia, citing insufficient efficacy data and requesting another trial. Jazz Pharmaceuticals secured approval for dordaviprone to treat rare pediatric brain tumors.
25 August 2025
······

Stock Market Today

  • Zacks Lists Albany International, Equifax, Cigna as Strong Sell Stocks on March 20
    March 20, 2026, 7:07 AM EDT. Zacks Investment Research added Albany International (AIN), Equifax (EFX), and Cigna Group (CI) to its Rank #5 Strong Sell list on March 20. Albany International saw a 16.5% earnings estimate cut over 60 days, Equifax's forecasts dropped 12.1%, and Cigna's fell by 6.3%. These downward earnings revisions signal caution for investors amid uncertain market conditions. Separately, Zacks highlighted a new top semiconductor stock expected to benefit from booming demand in AI and IoT, contrasting its tiny size with NVIDIA's 800% rally. Zacks projects the semiconductor market to surge from $452 billion in 2021 to $803 billion by 2028. These insights guide investors amid shifting earnings outlooks and tech sector growth.
Go toTop